Swiss Biotech Report: Sunrise, not sunset,...In 2022, the Swiss biotech industry "continued to demonstrate its resilience, adapting well to geopolitical upheavals and remaining a key driver of innovation for global healthcare". Swiss … more ➔
Novartis in US$465m deal with 3B Pharmaceu...Targeted radiopharmaceuticals maker 3B Pharmaceuticals snaps US$40m upfront in a global exclusive licensing agreement for its FAP-Targeting Peptide Technology. more ➔
partnershipSyngenta partners with BiotalysSyngenta has announced to leverage Biotalys AGROBODY technology platform to expand its biocontrol pipeline. more ➔
Phialogics AG bags pre-seed financingPhialogics AG has got a €600,000 pre-seed financing from German HTGF to validate its approach to rebalance the immune system of people with auto-immune diseases. more ➔
Forbion raises €1.35bn across two fundsEuropean life sciences venture capital company Forbion has raised two oversubscribed funds totalling €1.35 bn. more ➔
Ariceum Therapeutics extends Series A to ...German radiopharmaceuticals developer Ariceum Therapeutics has raised a further €22.75m extension of its €25m Series A financing announced in June 2022. more ➔
CollaborationGenmab and argenx combine antibody know-ho...Genmab and argenx have entered a multiyear collaboration bringing together capabilities to jointly discover, develop and commercialise antibody  … more ➔
Adaptyv Biosytems launches protein enginee...Swiss Adaptyv Biosystems Sàrl has launched two fast-feedback tools that allow cheap, rapid and minaturised validation of AI-designed proteins. more ➔
Researchers activate chemotherapeutics by...Ultrasound that switches cancer drug on could significantly reduce chemotherapy side effects, German researchers found in preclinical studies. more ➔
FAO presents food safety assessment on cel...At the beginning of April, the FAO presented a report entitled "Food safety aspects of cell-based food" to establish safety standards for cell-based proteins. more ➔
